Combined oral contraceptives: evolution of the relationship benefit/risk
Currently, more than 100 million women worldwide use combined oral contraceptives. Risk/benefit ratio of this group of drugs over the half-century history is largely changed in the direction of safety. The factors that increase the safety of this group of drugs, as well as the main risk factors are...
Main Author: | O. S. Alyautdina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/57 |
Similar Items
-
Rationale for the use of combined oral contraceptives with metafolin in young women
by: E. V. Uvarova
Published: (2014-12-01) -
Administration of combined contraceptive containing dienogest and ethinyl estradiol for endometriosis
by: L. V. Yerofeyeva
Published: (2016-12-01) -
Kombinirovannye oral'nye kontratseptivy v terapii akne u zhenshchin
by: I M Korsunskaya, et al.
Published: (2007-04-01) -
Novyy oral'nyy kontratseptiv s antimineralokortikoidnymi i antiandrogennymi svoystvami: effektivnost' i perenosimost' (rezul'taty mnogotsentrovogo 6-mesyachnogo nablyudeniya na Ukraine)
by: I B Vovk, et al.
Published: (2005-02-01) -
Androgenzavisimaya dermopatiya kak proyavlenie sindroma giperandrogenii: metody korrektsii
by: Yu E Dobrokhotova, et al.
Published: (2006-10-01)